mRNA Vaccines Market Report

China mRNA Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Aug 30, 2023
  • PAGES：182
  • REPORT CODE：GMM1766682
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the mRNA Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Moderna Therapeutics

    • In-Cell-Art

    • Tiba Biotechnology

    • Argos Therapeutics

    • eTheRNA

    • Sangamo Therapeutics

    • BioNTech

    • CureVac

    • Ethris

    By Type:

    • Cancer Vaccines

    • Intratumoral Immuno-Oncology

    • COVID-19 Vaccines

    • Other Prophylactic Vaccines

    By Application:

    • Infectious Disease

    • Others

    • Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China mRNA Vaccines Market Overview 2018-2029

    • 1.1 China mRNA Vaccines Industry Development Overview

    • 1.2 China mRNA Vaccines Industry Development History

    • 1.3 China mRNA Vaccines Industry Market Size (2018-2029)

    • 1.4 China mRNA Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China mRNA Vaccines Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

      • 1.4.2 China mRNA Vaccines Production Volume, Production Value and Growth Rate of Intratumoral Immuno-Oncology (2018-2029)

      • 1.4.3 China mRNA Vaccines Production Volume, Production Value and Growth Rate of COVID-19 Vaccines (2018-2029)

      • 1.4.4 China mRNA Vaccines Production Volume, Production Value and Growth Rate of Other Prophylactic Vaccines (2018-2029)

    • 1.5 China mRNA Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)

      • 1.5.2 China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • 1.6 China mRNA Vaccines Market Analysis by Region

      • 1.6.1 North China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China mRNA Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China mRNA Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on mRNA Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China mRNA Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China mRNA Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China mRNA Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on mRNA Vaccines Industry Development

    Chapter 3 mRNA VaccinesIndustry Chain Analysis

    • 3.1 mRNA Vaccines Industry Chain

    • 3.2 mRNA Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the mRNA Vaccines Market

    • 3.3 mRNA Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the mRNA Vaccines Market

    Chapter 4 China mRNA Vaccines Market, by Type

    • 4.1 China mRNA Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China mRNA Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China mRNA Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China mRNA Vaccines Production Volume and Growth Rate of Cancer Vaccines

      • 4.5.2 China mRNA Vaccines Production Volume and Growth Rate of Intratumoral Immuno-Oncology

      • 4.5.3 China mRNA Vaccines Production Volume and Growth Rate of COVID-19 Vaccines

      • 4.5.4 China mRNA Vaccines Production Volume and Growth Rate of Other Prophylactic Vaccines

    Chapter 5 China mRNA Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China mRNA Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China mRNA Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China mRNA Vaccines Market Size and Growth Rate of Infectious Disease

      • 5.5.2 China mRNA Vaccines Market Size and Growth Rate of Others

      • 5.5.3 China mRNA Vaccines Market Size and Growth Rate of Cancer

    Chapter 6 China mRNA Vaccines Market, by Region

    • 6.1 China mRNA Vaccines Production Volume and Production Value, by Region

    • 6.2 China mRNA Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China mRNA Vaccines Market Analysis

    • 7.1 North China mRNA Vaccines Market, by Type

    • 7.2 North China mRNA Vaccines Market, by Application

    Chapter 8 Central China mRNA Vaccines Market Analysis

    • 8.1 Central China mRNA Vaccines Market, by Type

    • 8.2 Central China mRNA Vaccines Market, by Application

    Chapter 9 South China mRNA Vaccines Market Analysis

    • 9.1 South China mRNA Vaccines Market, by Type

    • 9.2 South China mRNA Vaccines Market, by Application

    Chapter 10 East China mRNA Vaccines Market Analysis

    • 10.1 East China mRNA Vaccines Market, by Type

    • 10.2 East China mRNA Vaccines Market, by Application

    Chapter 11 Northeast China mRNA Vaccines Market Analysis

    • 11.1 Northeast China mRNA Vaccines Market, by Type

    • 11.2 Northeast China mRNA Vaccines Market, by Application

    Chapter 12 Southwest China mRNA Vaccines Market Analysis

    • 12.1 Southwest China mRNA Vaccines Market, by Type

    • 12.2 Southwest China mRNA Vaccines Market, by Application

    Chapter 13 Northwest China mRNA Vaccines Market Analysis

    • 13.1 Northwest China mRNA Vaccines Market, by Type

    • 13.2 Northwest China mRNA Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Moderna Therapeutics

        • 14.1.1 Moderna Therapeutics Company Profile

        • 14.1.2 Moderna Therapeutics mRNA Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 In-Cell-Art

        • 14.2.1 In-Cell-Art Company Profile

        • 14.2.2 In-Cell-Art mRNA Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Tiba Biotechnology

        • 14.3.1 Tiba Biotechnology Company Profile

        • 14.3.2 Tiba Biotechnology mRNA Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Argos Therapeutics

        • 14.4.1 Argos Therapeutics Company Profile

        • 14.4.2 Argos Therapeutics mRNA Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 eTheRNA

        • 14.5.1 eTheRNA Company Profile

        • 14.5.2 eTheRNA mRNA Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sangamo Therapeutics

        • 14.6.1 Sangamo Therapeutics Company Profile

        • 14.6.2 Sangamo Therapeutics mRNA Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BioNTech

        • 14.7.1 BioNTech Company Profile

        • 14.7.2 BioNTech mRNA Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 CureVac

        • 14.8.1 CureVac Company Profile

        • 14.8.2 CureVac mRNA Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Ethris

        • 14.9.1 Ethris Company Profile

        • 14.9.2 Ethris mRNA Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 mRNA Vaccines Industry Research Conclusions

    • 15.2 mRNA Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China mRNA Vaccines Industry Market Size (2018-2029)

    • Figure China mRNA Vaccines Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

    • Figure China mRNA Vaccines Production Volume, Production Value and Growth Rate of Intratumoral Immuno-Oncology (2018-2029)

    • Figure China mRNA Vaccines Production Volume, Production Value and Growth Rate of COVID-19 Vaccines (2018-2029)

    • Figure China mRNA Vaccines Production Volume, Production Value and Growth Rate of Other Prophylactic Vaccines (2018-2029)

    • Figure China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Infectious Disease (2018-2029)

    • Figure China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China mRNA Vaccines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure North China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China mRNA Vaccines Market Size and Growth Rate from 2018-2029

    • Figure mRNA Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China mRNA Vaccines Market Share by Type in 2018

    • Figure China mRNA Vaccines Market Share by Type in 2023

    • Figure China mRNA Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China mRNA Vaccines Production Volume and Growth Rate of Cancer Vaccines (2018-2023)

    • Figure China mRNA Vaccines Production Volume and Growth Rate of Intratumoral Immuno-Oncology (2018-2023)

    • Figure China mRNA Vaccines Production Volume and Growth Rate of COVID-19 Vaccines (2018-2023)

    • Figure China mRNA Vaccines Production Volume and Growth Rate of Other Prophylactic Vaccines (2018-2023)

    • Figure China mRNA Vaccines Market Share by Application in 2018

    • Figure China mRNA Vaccines Market Share by Application in 2023

    • Figure China mRNA Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China mRNA Vaccines Market Size and Growth Rate of Infectious Disease (2018-2023)

    • Figure China mRNA Vaccines Market Size and Growth Rate of Others (2018-2023)

    • Figure China mRNA Vaccines Market Size and Growth Rate of Cancer (2018-2023)

    • Table China mRNA Vaccines Production Volume by Region (2018-2023)

    • Table China mRNA Vaccines Production Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccines Production Volume Share by Region (2018-2023)

    • Table China mRNA Vaccines Production Value by Region (2018-2023)

    • Table China mRNA Vaccines Production Value Share by Region (2018-2023)

    • Figure China mRNA Vaccines Production Value Share by Region (2018-2023)

    • Table China mRNA Vaccines Sales Volume by Region (2018-2023)

    • Table China mRNA Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccines Sales Volume Share by Region (2018-2023)

    • Table China mRNA Vaccines Sales Value by Region (2018-2023)

    • Table China mRNA Vaccines Sales Value Share by Region (2018-2023)

    • Figure China mRNA Vaccines Sales Value Share by Region (2018-2023)

    • Table North China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table North China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table North China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table North China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table Central China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table Central China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table South China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table South China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table South China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table East China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table East China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table East China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China mRNA Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China mRNA Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China mRNA Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China mRNA Vaccines Sales Volume Share by Application (2018-2023)

    • Table Moderna Therapeutics Company Profile

    • Table Moderna Therapeutics mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table In-Cell-Art Company Profile

    • Table In-Cell-Art mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table Tiba Biotechnology Company Profile

    • Table Tiba Biotechnology mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table Argos Therapeutics Company Profile

    • Table Argos Therapeutics mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table eTheRNA Company Profile

    • Table eTheRNA mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sangamo Therapeutics Company Profile

    • Table Sangamo Therapeutics mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table BioNTech Company Profile

    • Table BioNTech mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table CureVac Company Profile

    • Table CureVac mRNA Vaccines Revenue, Price and Gross (2018-2023)

    • Table Ethris Company Profile

    • Table Ethris mRNA Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US